How did we get here? Until now, vaccines for all children under age 12 had been available under emergency use authorization ...

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

According to Pfizer, "Hundreds of millions of doses of the Pfizer-BioNTech COVID-19 vaccine have been administered globally, ...

US regulators have fully approved Moderna's Spikevax COVID-19 vaccine for children aged 6 months to 11 years, but only for ...

Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

Pfizer and Moderna will now include more information on the risk of myocarditis on their COVID-19 vaccine labels.

Pfizer's COVID vaccine (Comirnaty) is fully approved for patients ages 12 and up, and authorized for kids ages 6 months ...

BRUSSELS (CNS) — European Commission President Ursula von der Leyen defended herself before the European Parliament Monday as ...

The court determined that Pfizer (NYSE: PFE) and BioNTech’s (NASDAQ: BNTX) Comirnaty vaccine had infringed on this patent, making Moderna eligible for damages for sales after March 2022. In the same ...

"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...

Bangladesh is finally experiencing some relief. The virus has slowed down, with no new deaths or hospitalizations reported in ...